Today: 20 March 2026
Subscribe
Browse Category

LSE:BEZ.L 21 January 2026 - 5 March 2026

Beazley profit slides 19% as Zurich takeover advances and board adds PwC veteran Roy Clark

Beazley profit slides 19% as Zurich takeover advances and board adds PwC veteran Roy Clark

Beazley reported a 19% drop in annual pre-tax profit to $1.15 billion as cyber underwriting shrank and insurance pricing weakened. Zurich Insurance’s agreed takeover values Beazley at £8.1 billion, with shareholders set to receive 1,335 pence per share including a 25 pence dividend. Zurich raised $5 billion in a share sale to fund the deal. Beazley shares were little changed in early London trading.
5 March 2026
··
Zurich’s $11 billion Beazley takeover: the 1,335p offer, the financing, and what could derail it

Zurich’s $11 billion Beazley takeover: the 1,335p offer, the financing, and what could derail it

Zurich Insurance Group agreed to acquire Beazley for £8.1 billion ($10.8 billion) in cash. Beazley shareholders will receive 1,335 pence per share, including a 25 pence dividend. Zurich raised CHF 3.9 billion ($5.0 billion) through a new share placement to help fund the deal. The transaction is expected to close in the second half of 2026, pending approvals.
3 March 2026
··

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
Go toTop